Oral Delivery of Transformable Bilirubin Self‐Assembled System for Targeted Therapy of Colitis
Advanced Healthcare Materials · 2023
DOI: 10.1002/adhm.202300946 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Zhejie Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Macao Centre for Research and Development in Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Med…. Hauptthemen laut MEDLINE: Colitis, Colitis, Ulcerative. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Fundo para o Desenvolvimento das Ciências e da Tecnologia, Universidade de Macau.
Abstract (Originalsprache)
Ulcerative colitis (UC) is a high incidence disease worldwide and clinically presents as relapsing and incurable inflammation of the colon. Bilirubin (BR), a natural antioxidant with significant anti‐colitic effects, is utilized in preclinical studies as an intestinal disease therapy. Due to their water‐insolubility, the design of BR‐based agents usually involves complicated chemosynthetic processes, introducing various uncertainties in BR development. After screening numerous materials, it is identified that chondroitin sulfate can efficiently mediate the construction of BR self‐assembled nanomedicine (BSNM) via intermolecular hydrogen bonds between dense sulfate and carboxyl of chondroitin sulfate and imino groups of BR. BSNM exhibits pH sensitivity and reactive oxygen species responsiveness, enabling targeted delivery to the colon. After oral administration, BSNM significantly inhibits colonic fibrosis and apoptosis of colon and goblet cells; it also reduces the expression of inflammatory cytokines. Moreover, BSNM maintains the normal level of zonula occludens‐1 and occludin to sustain the integrity of intestinal barrier, regulates the macrophage polarization from M1 to M2 type, and promotes the ecological recovery of intestinal flora. Collectively, the work provides a colon‐targeted and transformable BSNM that is simple to prepare and is useful as an efficient targeted UC therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Macao Centre for Research and Development in Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, 999078, China.
- College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
- Department of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, 519090, China.
ORCID-Profile: Shengpeng Wang
Förderung
- Fundo para o Desenvolvimento das Ciências e da Tecnologia
- Universidade de Macau
Zitieren
APA
Chen, Z., Chen, Y., Hao, W., Shui, M., Zhang, J., Zhou, H., Zhang, C., Wang, Y., & Wang, S. (2023). Oral Delivery of Transformable Bilirubin Self‐Assembled System for Targeted Therapy of Colitis. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202300946
Vancouver
Chen Z, Chen Y, Hao W, Shui M, Zhang J, Zhou H, et al. Oral Delivery of Transformable Bilirubin Self‐Assembled System for Targeted Therapy of Colitis. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202300946
BibTeX
@article{Chen2023,
author = {Chen, Zhejie and Chen, Yi and Hao, Wei and Shui, Mingju and Zhang, Jinming and Zhou, Hefeng and Zhang, Chen and Wang, Yitao and Wang, Shengpeng},
title = {Oral Delivery of Transformable Bilirubin Self‐Assembled System for Targeted Therapy of Colitis},
journal = {Advanced Healthcare Materials},
year = {2023},
doi = {10.1002/adhm.202300946}
}
EUVIMED